According to Assertio Therapeutics 's latest financial reports the company's total assets are $0.28 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.28 B | -30.8% |
2022-12-31 | $0.41 B | 26.75% |
2021-12-31 | $0.32 B | 7.67% |
2020-12-31 | $0.30 B | -42.47% |
2019-12-31 | $0.52 B | -43.49% |
2018-12-31 | $0.93 B | -10.18% |
2017-12-31 | $1.03 B | -15.24% |
2016-12-31 | $1.22 B | -9.72% |
2015-12-31 | $1.35 B | 90.88% |
2014-12-31 | $0.71 B | 39.79% |
2013-12-31 | $0.50 B | 259.08% |
2012-12-31 | $0.14 B | -13.82% |
2011-12-31 | $0.16 B | 88.87% |
2010-12-31 | $87.03 M | -4.97% |
2009-12-31 | $91.58 M | -3.68% |
2008-12-31 | $95.08 M | 17.9% |
2007-12-31 | $80.64 M | 53.27% |
2006-12-31 | $52.61 M | -20.77% |
2005-12-31 | $66.41 M | 190.42% |
2004-12-31 | $22.86 M | -52.05% |
2003-12-31 | $47.69 M | 105.76% |
2002-12-31 | $23.17 M | 165% |
2001-12-31 | $8.74 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $2.01 B | 602.36% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $22.68 M | -92.08% | ๐บ๐ธ USA |